PETERSON RICHARD D 4
4 · Sienna Biopharmaceuticals, Inc. · Filed Jul 27, 2017
Insider Transaction Report
Form 4
PETERSON RICHARD D
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-07-26+8,518→ 8,518 totalExercise: $15.00Exp: 2027-07-26→ Common Stock (8,518 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from July 26, 2017, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.